Efficacy and safety of doxepin 6 mg in a 4-week outpatient trial of elderly adults with primary insomnia

被引：0
|
作者：
Lankford, A. [1 ]
Segal, S. [2 ]
Borders, J. [3 ]
Anderson, D.
Durrence, H. [4 ]
Rogowski, R. [4 ]
Ludington, E. [4 ]
Roth, T. [5 ]
机构：
[1] Sleep Disorders Ctr Georgia, Atlanta, GA USA
[2] Sci Inst Clin Res, N Miami, DC USA
[3] Cent Kentucky Res Associates Inc, Lexington, KY USA
[4] Somaxon Pharmaceut Inc, San Diego, CA USA
[5] Henry Ford Sleep Disorders Ctr, Detroit, MI USA
来源：
SLEEP | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
782
引用
收藏
页码：A256 / A256
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia
    Lankford, Alan
    Rogowski, Roberta
    Essink, Beal
    Ludington, Elizabeth
    Durrence, H. Heith
    Roth, Thomas
    [J]. SLEEP MEDICINE, 2012, 13 (02) : 133 - 138
  • [2] Efficacy and safety of doxepin 3 and 6 mg in adults with primary insomnia
    Lankford, A.
    Hull, S.
    Scharf, M.
    Schwartz, H.
    Seiden, D.
    Jochelson, P.
    Rogowski, R.
    Roth, T.
    Group, S.
    [J]. SLEEP, 2007, 30 : A256 - A256
  • [3] Efficacy and safety of doxepin 1, 3, and 6mg in elderly adults with primary insomnia
    Roth, T.
    Rogowski, R.
    Hull, S.
    Cohn, M.
    Lankford, A.
    Mayleben, D.
    Scharf, M.
    [J]. SLEEP, 2006, 29 : A239 - A240
  • [4] Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia
    Krystal, Andrew D.
    Durrence, H. Heith
    Scharf, Martin
    Jochelson, Philip
    Rogowski, Roberta
    Ludington, Elizabeth
    Roth, Thomas
    [J]. SLEEP, 2010, 33 (11) : 1553 - 1561
  • [5] Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia
    Roth, Thomas
    Rogowski, Roberta
    Hull, Steven
    Schwartz, Howard
    Koshorek, Gail
    Corser, Bruce
    Seiden, David
    Lankford, Alan
    [J]. SLEEP, 2007, 30 (11) : 1555 - 1561
  • [6] Efficacy and safety of doxepin 1 and 3 mg in a 3-month trial of elderly adults with chronic primary insomnia
    Roth, T.
    Durrence, H.
    Gotfried, M.
    Hull, S.
    Corser, B.
    Scharf, M.
    Orr, W.
    Buddharaju, V
    Schwartz, H.
    Jochelson, P.
    [J]. SLEEP, 2008, 31 : A230 - A230
  • [7] Efficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary Insomnia
    Krystal, Andrew D.
    Lankford, Alan
    Durrence, H. Heith
    Ludington, Elizabeth
    Jochelson, Philip
    Rogowski, Roberta
    Roth, Thomas
    [J]. SLEEP, 2011, 34 (10) : 1433 - 1442
  • [8] Efficacy and safety of doxepin 6 mg in a model of transient insomnia
    Schwartz, H.
    Hull, S.
    Seiden, D.
    Rogowski, R.
    Jochelson, P.
    Peterson, G.
    Ludington, E.
    Durrence, H.
    Roth, T.
    [J]. SLEEP, 2007, 30 : A266 - A266
  • [9] Efficacy and safety of doxepin 6 mg in a model of transient insomnia
    Roth, Thomas
    Durrence, H. Heith
    Jochelson, Philip
    Peterson, Gregg
    Ludington, Elizabeth
    Rogowski, Roberta
    Scharf, Martin
    Lankford, Alan
    [J]. SLEEP MEDICINE, 2010, 11 (09) : 843 - 847
  • [10] Efficacy of doxepin 3 and 6 mg on early morning awakenings in adults with primary insomnia
    Krystal, A.
    Lankford, A.
    Durrence, H.
    Jochelson, P.
    Rogowski, R.
    Kittrelle, J.
    Roth, T.
    [J]. SLEEP, 2008, 31 : A257 - A257
12345